NO20074964L - Pyrimidinderivater for behandling av hyperproliferative forstyrrelser - Google Patents
Pyrimidinderivater for behandling av hyperproliferative forstyrrelserInfo
- Publication number
- NO20074964L NO20074964L NO20074964A NO20074964A NO20074964L NO 20074964 L NO20074964 L NO 20074964L NO 20074964 A NO20074964 A NO 20074964A NO 20074964 A NO20074964 A NO 20074964A NO 20074964 L NO20074964 L NO 20074964L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pyrimidine derivatives
- hyperproliferative disorders
- compounds
- hyperproliferative
- Prior art date
Links
- 230000003463 hyperproliferative effect Effects 0.000 title abstract 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract 2
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66056105P | 2005-03-10 | 2005-03-10 | |
| PCT/US2006/008779 WO2006099231A1 (en) | 2005-03-10 | 2006-03-09 | Pyrimidine derivatives for treatment of hyperproliferative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074964L true NO20074964L (no) | 2007-12-06 |
Family
ID=36624969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074964A NO20074964L (no) | 2005-03-10 | 2007-10-02 | Pyrimidinderivater for behandling av hyperproliferative forstyrrelser |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20110098301A1 (es) |
| EP (1) | EP1858882A1 (es) |
| JP (1) | JP2008533042A (es) |
| KR (1) | KR20080004488A (es) |
| CN (1) | CN101151258A (es) |
| AR (1) | AR053554A1 (es) |
| AU (1) | AU2006223199A1 (es) |
| BR (1) | BRPI0609022A2 (es) |
| CA (1) | CA2601257A1 (es) |
| CR (1) | CR9347A (es) |
| DO (1) | DOP2006000061A (es) |
| EA (1) | EA200701930A1 (es) |
| GT (1) | GT200600105A (es) |
| IL (1) | IL185498A0 (es) |
| MA (1) | MA29377B1 (es) |
| MX (1) | MX2007010102A (es) |
| NO (1) | NO20074964L (es) |
| PE (1) | PE20061067A1 (es) |
| TN (1) | TNSN07322A1 (es) |
| TW (1) | TW200724537A (es) |
| UY (1) | UY29414A1 (es) |
| WO (1) | WO2006099231A1 (es) |
| ZA (1) | ZA200708591B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2001477A4 (en) * | 2006-03-20 | 2010-07-21 | Bayer Healthcare Llc | COMBINATION OF PACLITAXEL |
| CA2694275A1 (en) * | 2007-07-26 | 2009-01-29 | Novartis Ag | Organic compounds |
| DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| EP2621486A1 (en) | 2010-10-01 | 2013-08-07 | Bayer Intellectual Property GmbH | Substituted n-(2-arylamino)aryl sulfonamide-containing combinations |
| CN103270026A (zh) | 2010-12-21 | 2013-08-28 | 诺瓦提斯公司 | 作为vps34抑制剂的联-杂芳基化合物 |
| EP4328223A3 (en) | 2011-04-22 | 2024-11-06 | Signal Pharmaceuticals, LLC | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| DK2922828T3 (da) | 2012-11-21 | 2020-08-31 | Ptc Therapeutics Inc | 4,6-diamino-pyrimidin-derivater som bmi-1-inhibitorer til at behandle cancer |
| CN103408573B (zh) * | 2013-07-12 | 2015-12-23 | 上海工程技术大学 | 硼酸衍生物及其制备方法和应用 |
| CA2922657C (en) * | 2013-08-30 | 2022-04-12 | Ptc Therapeutics, Inc. | Substituted pyrimidine bmi-1 inhibitors |
| US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
| NZ715903A (en) | 2014-01-30 | 2017-06-30 | Signal Pharm Llc | Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use |
| US9638690B2 (en) | 2014-11-07 | 2017-05-02 | The University Of British Columbia | Compounds and compositions for use as alkylating agent sensors and methods of use thereof |
| US20180022710A1 (en) | 2015-01-29 | 2018-01-25 | Signal Pharmaceuticals, Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| WO2017019487A1 (en) | 2015-07-24 | 2017-02-02 | Celgene Corporation | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
| TWI609028B (zh) | 2016-05-06 | 2017-12-21 | 財團法人工業技術研究院 | 共聚物與含其之樹脂組合物、封裝膜及封裝結構 |
| BR112021002630A2 (pt) | 2018-08-17 | 2021-05-11 | Ptc Therapeutics, Inc. | método para tratar câncer pancreático |
| CN111518078B (zh) * | 2020-05-30 | 2021-02-26 | 南方医科大学 | 一种含氨基吡啶的嘧啶类化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3089480B2 (ja) * | 1990-09-20 | 2000-09-18 | ソニー株式会社 | フリットシール装置 |
| EP1470121B1 (en) * | 2002-01-23 | 2012-07-11 | Bayer HealthCare LLC | Pyrimidine derivatives as rho-kinase inhibitors |
| ATE381557T1 (de) * | 2002-01-23 | 2008-01-15 | Bayer Pharmaceuticals Corp | Rho-kinase inhibitoren |
| JP4948173B2 (ja) * | 2003-10-10 | 2012-06-06 | ニツポネツクス・インコーポレーテツド | 過剰増殖性疾患治療用ピリミジン誘導体 |
-
2006
- 2006-03-09 JP JP2008501008A patent/JP2008533042A/ja active Pending
- 2006-03-09 UY UY29414A patent/UY29414A1/es not_active Application Discontinuation
- 2006-03-09 DO DO2006000061A patent/DOP2006000061A/es unknown
- 2006-03-09 PE PE2006000271A patent/PE20061067A1/es not_active Application Discontinuation
- 2006-03-09 TW TW095107853A patent/TW200724537A/zh unknown
- 2006-03-09 GT GT200600105A patent/GT200600105A/es unknown
- 2006-03-09 MX MX2007010102A patent/MX2007010102A/es not_active Application Discontinuation
- 2006-03-09 EP EP06737910A patent/EP1858882A1/en not_active Withdrawn
- 2006-03-09 US US11/886,132 patent/US20110098301A1/en not_active Abandoned
- 2006-03-09 EA EA200701930A patent/EA200701930A1/ru unknown
- 2006-03-09 AU AU2006223199A patent/AU2006223199A1/en not_active Abandoned
- 2006-03-09 CN CNA2006800077914A patent/CN101151258A/zh active Pending
- 2006-03-09 WO PCT/US2006/008779 patent/WO2006099231A1/en not_active Ceased
- 2006-03-09 KR KR1020077023009A patent/KR20080004488A/ko not_active Withdrawn
- 2006-03-09 BR BRPI0609022-2A patent/BRPI0609022A2/pt not_active IP Right Cessation
- 2006-03-09 CA CA002601257A patent/CA2601257A1/en not_active Abandoned
- 2006-03-10 AR ARP060100919A patent/AR053554A1/es not_active Application Discontinuation
-
2007
- 2007-08-22 TN TNP2007000322A patent/TNSN07322A1/en unknown
- 2007-08-23 IL IL185498A patent/IL185498A0/en unknown
- 2007-08-28 CR CR9347A patent/CR9347A/es not_active Application Discontinuation
- 2007-10-02 MA MA30266A patent/MA29377B1/fr unknown
- 2007-10-02 NO NO20074964A patent/NO20074964L/no not_active Application Discontinuation
- 2007-10-09 ZA ZA200708591A patent/ZA200708591B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY29414A1 (es) | 2006-10-02 |
| CR9347A (es) | 2007-12-17 |
| KR20080004488A (ko) | 2008-01-09 |
| IL185498A0 (en) | 2008-01-06 |
| PE20061067A1 (es) | 2006-11-30 |
| TNSN07322A1 (en) | 2008-12-31 |
| MX2007010102A (es) | 2007-10-12 |
| GT200600105A (es) | 2007-02-14 |
| ZA200708591B (en) | 2009-01-28 |
| WO2006099231A1 (en) | 2006-09-21 |
| MA29377B1 (fr) | 2008-04-01 |
| JP2008533042A (ja) | 2008-08-21 |
| CN101151258A (zh) | 2008-03-26 |
| EA200701930A1 (ru) | 2008-02-28 |
| AR053554A1 (es) | 2007-05-09 |
| BRPI0609022A2 (pt) | 2010-01-12 |
| DOP2006000061A (es) | 2006-09-30 |
| TW200724537A (en) | 2007-07-01 |
| AU2006223199A1 (en) | 2006-09-21 |
| EP1858882A1 (en) | 2007-11-28 |
| CA2601257A1 (en) | 2006-09-21 |
| US20110098301A1 (en) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074964L (no) | Pyrimidinderivater for behandling av hyperproliferative forstyrrelser | |
| MY149960A (en) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases | |
| MX2008005398A (es) | Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer. | |
| NO20085217L (no) | Effektive pyrimidinderivater i behandlingen av kreft | |
| WO2006123113A3 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| NO20045677L (no) | Inhibitorer av JAK- og CDK2-proteinkinaser | |
| NO20070681L (no) | 2, 4, 6-Trisubstituterte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse i behandling av kreft | |
| NO20090631L (no) | Morpholin pyrimidin derivativer anvendelige i behandlingen av proliferative lidelser | |
| WO2005110994A3 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
| NO20092658L (no) | New compounds | |
| NO20082088L (no) | Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer | |
| MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
| IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
| EA200802050A1 (ru) | Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов | |
| NO20070655L (no) | 2,4,6-Trisubstituerte pyrimidiner som fosfotidylinositol-(PI)-3-kinaseinhibitorer og disses anvendelse ved behandling av kreft | |
| PL1853602T3 (pl) | Związki chemiczne | |
| SI1853588T1 (sl) | Kemične spojine | |
| NO20071320L (no) | Pyrazolsubstituerte aminoheteroarylforbindelser som protein kinase inhibitorer. | |
| NO20091864L (no) | Forbindelser for inhibering av mitotisk progresjon | |
| IL181271A0 (en) | Triazolophthalazine derivatives and pharmaceutical compositions containing the same | |
| NO20080418L (no) | Pyrido[2,3-D]pyrimidiriderivater, fremgangsmate for fremstilling derav og terapeutisk anvendelse av samme | |
| WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
| WO2008104473A3 (en) | Pyrazolopyriidine derivatives and their use as kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |